日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study

在既往未接受治疗的弥漫性大B细胞淋巴瘤(DLBCL)患者中,Mosunetuzumab联合Pola-CHP方案与Pola-R-CHP方案的比较:一项2期研究的最终结果

Westin, Jason; Phillips, Tycel J; Mehta, Amitkumar; Hoffmann, Marc S; Gonzalez-Barca, Eva; Thieblemont, Catherine; Bastos-Oreiro, Mariana; Greil, Richard; Giebel, Sebastian; Wei, Michael C; Wang, Jue; Bucher, Reinhard; Sit, Jason; Penuel, Elicia; Purev, Enkhtsetseg; Yee, Donald L; Bergua-Burgues, Juan Miguel

The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study

PI3Kδ抑制剂zandelisib间歇给药治疗复发/难治性滤泡性淋巴瘤:一项全球II期研究的结果

Zelenetz, Andrew D; Jurczak, Wojciech; Ribrag, Vincent; Linton, Kim; Collins, Graham P; Jiménez, Javier L; Bishton, Mark; Dholaria, Bhagirathbhai; Mengarelli, Andrea; Phillips, Tycel J; Sungala, Nagendraprasad; Musuraca, Gerardo; Sheehy, Oonagh; Van Den Neste, Eric; Odera, Mitsuhiko; Miao, Lu; Gold, Daniel P; Ghalie, Richard G; Zinzani, Pier L

A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)

PI3Kδ抑制剂parsaclisib治疗复发和难治性边缘区淋巴瘤的II期研究(CITADEL-204)

Phillips, Tycel J; Avigdor, Abraham; Gurion, Ronit; Patti, Caterina; Corradini, Paolo; Tani, Monica; Mehta, Amitkumar; Lossos, Izidore S; Zinzani, Pier Luigi; Thieblemont, Catherine; Jurczak, Wojciech; Zheng, Fred; Rappold, Erica; Zhao, Wanying; Jiang, Ping; Johnson, Peter

Taking a BiTE out of Lymphoma: Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma

从淋巴瘤中移除双特异性抗体:B细胞非霍奇金淋巴瘤中的双特异性抗体

Weiss, Jonathan M; Phillips, Tycel J

Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

临床病理特征的综合分析定义了免疫化疗时代套细胞淋巴瘤的新型预后模型:来自北美套细胞淋巴瘤联盟的报告

Vose, Julie M; Fu, Kai; Wang, Lu; Mansoor, Adnan; Stewart, Douglas; Cheng, Hongxia; Smith, Lynette; Yuan, Ji; Qureishi, Hina Naushad; Link, Brian K; Cessna, Melissa H; Barr, Paul M; Kahl, Brad S; Mckinney, Matthew S; Khan, Nadia; Advani, Ranjana H; Martin, Peter; Goy, Andre H; Phillips, Tycel J; Mehta, Amitkumar; Kamdar, Manali; Crump, Michael; Pro, Barbara; Flowers, Christopher R; Jacobson, Caron A; Smith, Sonali M; Stephens, Deborah M; Bachanova, Veronika; Jin, Zhaohui; Wu, Shishou; Hernandez-Ilizaliturri, Francisco; Torka, Pallawi; Anampa-Guzmán, Andrea; Kashef, Farshid; Li, Xing; Sharma, Sunandini; Greiner, Timothy C; Armitage, James O; Lunning, Matthew; Weisenburger, Dennis D; Bociek, Robert G; Iqbal, Javeed; Yu, Guohua; Bi, Chengfeng

Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study

莫苏妥珠单抗联合CHOP方案治疗既往未接受治疗的弥漫性大B细胞淋巴瘤:一项2期研究的安全性和有效性结果

Olszewski, Adam J; Phillips, Tycel J; Hoffmann, Marc S; Armand, Philippe; Kim, Tae Min; Yoon, Dok Hyun; Mehta, Amitkumar; Greil, Richard; Westin, Jason; Lossos, Izidore S; Munoz, Javier L; Sit, Jason; Wei, Michael C; Yang, Annie; Chen, Vivian; Purev, Enkhtsetseg; Yee, Donald L; Jaeger, Ulrich

Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis

复发/难治性套细胞淋巴瘤患者二线与后续治疗方案的长期疗效比较:一项更新的汇总分析

Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S; Simpson, David; Wang, Michael; Phillips, Tycel J; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun

COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma

接受靶向 CD20 的 T 细胞接合双特异性抗体治疗的 B 细胞非霍奇金淋巴瘤患者的 COVID-19 感染结局

Nachar, Victoria R; Perissinotti, Anthony J; Marini, Bernard L; Karimi, Yasmin H; Phillips, Tycel J

Burkitt Lymphoma International Prognostic Index

伯基特淋巴瘤国际预后指数

Olszewski, Adam J; Jakobsen, Lasse H; Collins, Graham P; Cwynarski, Kate; Bachanova, Veronika; Blum, Kristie A; Boughan, Kirsten M; Bower, Mark; Dalla Pria, Alessia; Danilov, Alexey; David, Kevin A; Diefenbach, Catherine; Ellin, Fredrik; Epperla, Narendranath; Farooq, Umar; Feldman, Tatyana A; Gerrie, Alina S; Jagadeesh, Deepa; Kamdar, Manali; Karmali, Reem; Kassam, Shireen; Kenkre, Vaishalee P; Khan, Nadia; Kim, Seo-Hyun; Klein, Andreas K; Lossos, Izidore S; Lunning, Matthew A; Martin, Peter; Martinez-Calle, Nicolas; Montoto, Silvia; Naik, Seema; Palmisiano, Neil; Peace, David; Phillips, Elizabeth H; Phillips, Tycel J; Portell, Craig A; Reddy, Nishitha; Santarsieri, Anna; Sarraf Yazdy, Maryam; Smeland, Knut B; Smith, Scott E; Smith, Stephen D; Sundaram, Suchitra; Zayac, Adam S; Zhang, Xiao-Yin; Zhu, Catherine; Cheah, Chan Y; El-Galaly, Tarec C; Evens, Andrew M

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials

泽布替尼单药治疗复发/难治性套细胞淋巴瘤:两项临床试验的汇总分析

Zhou, Keshu; Zou, Dehui; Zhou, Jianfeng; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S; Simpson, David; Wang, Michael; Phillips, Tycel J; Opat, Stephen; Huang, Zhiyue; Lu, Huafei; Song, Yuqin; Song, Yongping